BEARTOOTH BILLINGS CLINIC — History
CCN 271326 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$18M
Latest Revenue (FY2022)
+5.4%
Revenue CAGR (3yr)
-6.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $17M | $18M | $18M | +2.1% | +5.4% |
| Operating Expenses | $17M | $18M | $20M | +8.6% | +7.8% |
| Operating Margin | -1.9% | -0.3% | -6.6% | -2534.2% | +0.0% |
| Net Income | $-0M | $-0M | $-1M | -2589.6% | +0.0% |
| Licensed Beds | 10 | 10 | 10 | +0.0% | +0.0% |
| Total Patient Days | 2,277 | 1,824 | 1,663 | -8.8% | -14.5% |
| Medicare Day % | 62% | 49% | 55% | +11.8% | -5.8% |
| Medicaid Day % | 4% | 10% | 5% | -44.5% | +18.3% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +11.0% ($17M → $18M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.4%
This Hospital
+7.6%
State Avg
Latest Margin
-6.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $19M | -9.0% |
| FY2024 (proj) | $20M | -11.3% |
| FY2025 (proj) | $21M | -13.7% |